Department of Orthopedic Surgery, Keio University School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo 160-8582, Japan.
Department of Orthopedic Surgery, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan.
Bone. 2023 Jan;166:116570. doi: 10.1016/j.bone.2022.116570. Epub 2022 Sep 29.
It is mandatory to manage musculoskeletal disorders in the elderly to prevent their becoming bed-ridden or requiring long-term care. However, the prevalence of musculoskeletal disorders such as osteoporosis and sarcopenia in otherwise healthy people over 85 years old is not completely known. Here we enrolled 1026 healthy subjects between 85 and 89 years old and evaluated them for the presence of osteoporosis, sarcopenia and fragility fracture(s), and how those conditions were related. We also evaluated biomarkers such as serum levels of insulin-like growth factor 1 (IGF1) and vitamin D status. The prevalence of osteoporosis, sarcopenia or fragility fracture(s) in these subjects was 22.4, 10.2 or 15.0 %, respectively. Serum IGF1 and 25(OH)D were significantly and negatively correlated with osteoporosis or sarcopenia. Osteoporosis and either sarcopenia or fragility fracture(s) were significantly related and shown to be risk factors for each other, even after adjustment for gender and BMI, while sarcopenia and fragility fracture(s) were not associated. Our data may provide a health platform for the very elderly and suggest strategies to prevent musculoskeletal disorders in this population.
有必要对老年人的肌肉骨骼疾病进行管理,以防止其卧床不起或需要长期护理。然而,85 岁以上健康人群中骨质疏松症和肌少症等肌肉骨骼疾病的患病率尚不完全清楚。在这里,我们招募了 1026 名 85 至 89 岁的健康受试者,评估了他们是否存在骨质疏松症、肌少症和脆性骨折,并探讨了这些情况之间的关系。我们还评估了胰岛素样生长因子 1(IGF1)的血清水平等生物标志物和维生素 D 状况。这些受试者中骨质疏松症、肌少症或脆性骨折的患病率分别为 22.4%、10.2%和 15.0%。血清 IGF1 和 25(OH)D 与骨质疏松症或肌少症呈显著负相关。骨质疏松症与肌少症或脆性骨折均显著相关,且互为危险因素,即使在调整性别和 BMI 后也是如此,而肌少症与脆性骨折无相关性。我们的数据可能为非常老年人提供了一个健康平台,并为预防该人群的肌肉骨骼疾病提供了策略。